FDA Greenlights First Drug for Rare Immunodeficiency Disease

(MedPage Today) -- The FDA approved leniolisib (Joenja) on Friday as the first treatment indicated for activated phosphoinositide 3-kinase delta syndrome (APDS), a rare genetic disorder that causes progressive primary immunodeficiency. Leniolisib...
Source: MedPage Today Public Health - Category: American Health Source Type: news